Barclay Buck A. Phillips
2019
In 2019, Barclay Buck A. Phillips earned a total compensation of $1.2M as Former Chief Financial Officer and Senior Vice President, Corporate Development at G1 Therapeutics, a 70% increase compared to previous year.
Compensation breakdown
| Option Awards | $828,484 |
|---|---|
| Salary | $136,024 |
| Other | $247,453 |
| Total | $1,211,962 |
Phillips received $828.5K in option awards, accounting for 68% of the total pay in 2019.
Phillips also received $136K in salary and $247.5K in other compensation.
Rankings
In 2019, Barclay Buck A. Phillips' compensation ranked 8,381st out of 13,971 executives tracked by ExecPay. In other words, Phillips earned more than 40.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,381 out of 13,971 | 40th |
Division Manufacturing | 3,315 out of 5,698 | 42nd |
Major group Chemicals And Allied Products | 1,255 out of 2,197 | 43rd |
Industry group Drugs | 1,066 out of 1,883 | 43rd |
Industry Pharmaceutical Preparations | 791 out of 1,395 | 43rd |
Pay ratio
| Barclay Buck A. Phillips' Pay | $1,211,962 |
|---|---|
| Median Employee's Pay | $213,060 |
| Pay Ratio | 6to 1 |
In 2019, the annual total compensation of Barclay Buck A. Phillips was $1,211,962.
The annual total compensation of the median employee at G1 Therapeutics was $213,060.
The ratio of Barclay Buck A. Phillips' pay to the pay of median employee was therefore 6 to one.
Source: SEC filing on April 24, 2020.
Phillips' colleagues
We found five more compensation records of executives who worked with Barclay Buck A. Phillips at G1 Therapeutics in 2019.